Changes in background parenchymal enhancement in HER2-positive breast cancer before and after neoadjuvant chemotherapy: Association with pathologic complete response

This study aimed to analyze the relationship between pathologic complete response (pCR) and changes in background parenchymal enhancement (BPE) levels in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer and who received neoadjuvant chemotherapy (NAC). The pre- and...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Jing-Min, Wang, Hong-Xia, Zhong, Xiao-Fei, Xu, Kun, Bian, Jia, Feng, Yan, Chen, Liang, Zhang, Lin, Wang, Xia, Ma, De-Jing, Wang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221660/
https://www.ncbi.nlm.nih.gov/pubmed/30412117
http://dx.doi.org/10.1097/MD.0000000000012965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221660/
https://www.ncbi.nlm.nih.gov/pubmed/30412117
http://dx.doi.org/10.1097/MD.0000000000012965

Ejemplares similares